Combination Gerotherapeutic Interventions for Healthspan Improvement
Public ClinicalTrials.gov record NCT07475546. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Pilot Randomized Controlled Study of Combinatorial Gerotherapeutics for Healthspan Improvement
Study identification
- NCT ID
- NCT07475546
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AgelessRx
- Industry
- Enrollment
- 30 participants
Conditions and interventions
Conditions
Interventions
- B12 Dietary Supplement
- Control: Podcast Listening Activity Behavioral
- Control: Standard Exercise Regimen Behavioral
- GSH Drug
- Infinite Supplement Dietary Supplement
- Intervention: Guided Meditation Program Behavioral
- Intervention: Structured Exercise Program Behavioral
- Metformin Drug
- NAD+ Drug
- Naltrexone Drug
- Placebo/control Drug
- Rapamycin Drug
Dietary Supplement · Behavioral · Drug
Eligibility (public fields only)
- Age range
- 60 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 22, 2025
- Primary completion
- Mar 31, 2026
- Completion
- Mar 31, 2026
- Last update posted
- Mar 15, 2026
2025 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| AgelessRx | Ann Arbor | Michigan | 48104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07475546, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 15, 2026 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07475546 live on ClinicalTrials.gov.